1. Home
  2. Pharma & Healthcare
  3. Global Age Related Macular Degeneration Drug Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Age Related Macular Degeneration Drug Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 137 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Age Related Macular Degeneration Drug market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Age Related Macular Degeneration Drug market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Age Related Macular Degeneration Drug in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Lucentis
Eylea
Avastin
Other

Market Snapshot, By Application
Hospitals
Clinics
Other

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Roche
Regeneron Pharmaceuticals
Novartis
Kanghong Pharma
Bayer HealthCare

The study objectives of this report are:
To study and analyze the global Age Related Macular Degeneration Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Age Related Macular Degeneration Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Age Related Macular Degeneration Drug manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Age Related Macular Degeneration Drug market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Age Related Macular Degeneration Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Age Related Macular Degeneration Drug are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Age Related Macular Degeneration Drug Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Age Related Macular Degeneration Drug Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Age Related Macular Degeneration Drug

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Age Related Macular Degeneration Drug Sales Channel and Distributors Analysis
3.3.1 Age Related Macular Degeneration Drug Sales Channel
3.3.2 Age Related Macular Degeneration Drug Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Age Related Macular Degeneration Drug Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Age Related Macular Degeneration Drug Type Introduction
4.1.1 Lucentis
4.1.2 Eylea
4.1.3 Avastin
4.1.4 Other
4.2 Global Age Related Macular Degeneration Drug Sales by Type 2016-2021
4.3 Global Age Related Macular Degeneration Drug Revenue by Type 2016-2021
4.4 Global Age Related Macular Degeneration Drug Price by Type 2016-2021

5 Market Segment: by Application
5.1 Age Related Macular Degeneration Drug Type Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Other
5.2 Global Age Related Macular Degeneration Drug Sales by Application 2016-2021
5.3 Global Age Related Macular Degeneration Drug Revenue by Application 2016-2021
5.4 Global Age Related Macular Degeneration Drug Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Age Related Macular Degeneration Drug Market by Region
6.1.1 Global Age Related Macular Degeneration Drug Sales by Regions
6.1.2 Global Age Related Macular Degeneration Drug Revenue by Regions
6.2 North America Age Related Macular Degeneration Drug Market 2016-2021
6.3 Europe Age Related Macular Degeneration Drug Market 2016-2021
6.4 Asia Pacific Age Related Macular Degeneration Drug Market 2016-2021
6.5 South America Age Related Macular Degeneration Drug Market 2016-2021
6.6 Middle East and Africa Age Related Macular Degeneration Drug Market 2016-2021

7 North America
7.1 North America Age Related Macular Degeneration Drug Market by Country 2016-2021
7.1.1 North America Age Related Macular Degeneration Drug Sales by Country
7.1.2 North America Age Related Macular Degeneration Drug Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Age Related Macular Degeneration Drug Market by Country 2016-2021
8.1.1 Europe Age Related Macular Degeneration Drug Sales by Country
8.1.2 Europe Age Related Macular Degeneration Drug Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Age Related Macular Degeneration Drug Market by Country 2016-2021
9.1.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Country
9.1.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Age Related Macular Degeneration Drug Market by Country 2016-2021
10.1.1 South America Age Related Macular Degeneration Drug Sales by Country
10.1.2 South America Age Related Macular Degeneration Drug Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Age Related Macular Degeneration Drug Market by Country 2016-2021
11.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country
11.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
12.1.3 Roche Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Roche Key Development
12.2 Regeneron Pharmaceuticals
12.2.1 Regeneron Pharmaceuticals Company Information
12.2.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
12.2.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Regeneron Pharmaceuticals Key Development
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
12.3.3 Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Novartis Key Development
12.4 Kanghong Pharma
12.4.1 Kanghong Pharma Company Information
12.4.2 Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
12.4.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Kanghong Pharma Key Development
12.5 Bayer HealthCare
12.5.1 Bayer HealthCare Company Information
12.5.2 Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
12.5.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Bayer HealthCare Key Development

13 Global Age Related Macular Degeneration Drug Market Forecast by Region by Type and by Application
13.1 Global Age Related Macular Degeneration Drug Sales, Revenue Forecast 2022-2027
13.2 Global Age Related Macular Degeneration Drug Forecast by Regions
13.2.1 Global Age Related Macular Degeneration Drug Sales Forecast by Region 2022-2027
13.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region 2022-2027
13.3 Global Age Related Macular Degeneration Drug Forecast by Type
13.3.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type 2022-2027
13.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type 2022-2027
13.3.3 Global Age Related Macular Degeneration Drug Price Forecast by Type 2022-2027
13.4 Global Age Related Macular Degeneration Drug Forecast by Application
13.4.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application 2022-2027
13.4.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application 2022-2027
13.4.3 Global Age Related Macular Degeneration Drug Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Age Related Macular Degeneration Drug Production Specifications
Table 2: Drivers in Age Related Macular Degeneration Drug Market
Table 3: Restraints Age Related Macular Degeneration Drug Market
Table 4: Opportunity in Age Related Macular Degeneration Drug Market
Table 5: Comparion of Alternative and Age Related Macular Degeneration Drug
Table 6: Age Related Macular Degeneration Drug Raw Materials Key Suppliers List
Table 7: Age Related Macular Degeneration Drug Distributors List
Table 8: Age Related Macular Degeneration Drug Major Buyers in Application One
Table 9: Age Related Macular Degeneration Drug Major Buyers in Application Two
Table 10: Age Related Macular Degeneration Drug Major Buyers in Application Three
Table 11: Global Age Related Macular Degeneration Drug Sales (K Units) by Type 2016-2021
Table 12: Global Age Related Macular Degeneration Drug Sales Market Share by Type 2016-2021
Table 13: Global Age Related Macular Degeneration Drug Revenue (Million USD) by Type 2016-2021
Table 14: Global Age Related Macular Degeneration Drug Revenue Market Share by Type 2016-2021
Table 15: Global Age Related Macular Degeneration Drug Price by Type 2016-2021
Table 16: Global Age Related Macular Degeneration Drug Sales (K Units) by Application 2016-2021
Table 17: Global Age Related Macular Degeneration Drug Sales Market Share by Application 2016-2021
Table 18: Global Age Related Macular Degeneration Drug Revenue (Million USD) by Application 2016-2021
Table 19: Global Age Related Macular Degeneration Drug Revenue Market Share by Application 2016-2021
Table 20: Global Age Related Macular Degeneration Drug Price by Application 2016-2021
Table 21: Global Age Related Macular Degeneration Drug Sales (K Units) by Region 2016-2021
Table 22: Global Age Related Macular Degeneration Drug Sales Market Share by Region 2016-2021
Table 23: Global Age Related Macular Degeneration Drug Revenue (Million USD) by Region 2016-2021
Table 24: Global Age Related Macular Degeneration Drug Revenue Market Share by Region 2016-2021
Table 25: North America Age Related Macular Degeneration Drug Sales (K Units) by Country 2016-2021
Table 26: North America Age Related Macular Degeneration Drug Sales Market Share by Country 2016-2021
Table 27: North America Age Related Macular Degeneration Drug Revenue (Million USD) by Country 2016-2021
Table 28: North America Age Related Macular Degeneration Drug Revenue Market Share by Country 2016-2021)
Table 29: Europe Age Related Macular Degeneration Drug Sales (K Units) by Country 2016-2021
Table 30: Europe Age Related Macular Degeneration Drug Sales Market Share by Country 2016-2021
Table 31: Europe Age Related Macular Degeneration Drug Revenue (Million USD) by Country 2016-2021
Table 32: Europe Age Related Macular Degeneration Drug Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Age Related Macular Degeneration Drug Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Age Related Macular Degeneration Drug Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Country 2016-2021)
Table 37: South America Age Related Macular Degeneration Drug Sales (K Units) by Country 2016-2021
Table 38: South America Age Related Macular Degeneration Drug Sales Market Share by Country 2016-2021
Table 39: South America Age Related Macular Degeneration Drug Revenue (Million USD) by Country 2016-2021
Table 40: South America Age Related Macular Degeneration Drug Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Age Related Macular Degeneration Drug Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Age Related Macular Degeneration Drug Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Country 2016-2021)
Table 45 Roche Company Information
Table 46 Roche Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
Table 47 Roche Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Regeneron Pharmaceuticals Company Information
Table 49 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
Table 50 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Novartis Company Information
Table 52 Novartis Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
Table 53 Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Kanghong Pharma Company Information
Table 55 Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
Table 56 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Bayer HealthCare Company Information
Table 58 Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolio, Specification and Application
Table 59 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Age Related Macular Degeneration Drug Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Age Related Macular Degeneration Drug Picture
Figure 2: Global Age Related Macular Degeneration Drug Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Age Related Macular Degeneration Drug Supply Chain Analysis
Figure 5: Age Related Macular Degeneration Drug Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Lucentis
Figure 7: Product Picture of Eylea
Figure 8: Global Age Related Macular Degeneration Drug Sales Market Share by Type, 2020
Figure 9: Global Age Related Macular Degeneration Drug Revenue Market Share by Type, 2020
Figure 10: Age Related Macular Degeneration Drug in Hospitals
Figure 11: Global Age Related Macular Degeneration Drug Market: Hospitals 2016-2021
Figure 12: Age Related Macular Degeneration Drug in Clinics
Figure 13: Global Age Related Macular Degeneration Drug Market: Clinics 2016-2021
Figure 14: Global Age Related Macular Degeneration Drug Sales Market Share by Application, 2020
Figure 15: Global Age Related Macular Degeneration Drug Revenue Market Share by Application, 2020
Figure 16: Global Age Related Macular Degeneration Drug Sales Market Share by Region 2016-2021
Figure 17: Global Age Related Macular Degeneration Drug Revenue Market Share by Region 2016-2021
Figure 18: North America Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 19: North America Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 20: Europe Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 21: Europe Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 24: South America Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 25: South America Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 28: North America Age Related Macular Degeneration Drug Sales Market Share by Country, 2020
Figure 29: North America Age Related Macular Degeneration Drug Revenue Market Share by Country, 2020
Figure 30: United States Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 31: United States Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 32: Canada Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 33: Canada Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 35: Mexico Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 36: Europe Age Related Macular Degeneration Drug Sales Market Share by Country, 2020
Figure 37: Europe Age Related Macular Degeneration Drug Revenue Market Share by Country, 2020
Figure 38: Germany Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 39: Germany Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 40: France Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 41: France Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 42: UK Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 43: UK Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 44: Italy Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 45: Italy Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 46: Russia Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 46: Russia Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 47: Spain Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 48: Spain Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Country, 2020
Figure 50: Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Country, 2020
Figure 51: China Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 52: China Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 53: Japan Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 54: Japan Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 55: Korea Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 56: Korea Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 59: India Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 60: India Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 61: Australia Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 62: Australia Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 63: South America Age Related Macular Degeneration Drug Sales Market Share by Country, 2020
Figure 64: South America Age Related Macular Degeneration Drug Revenue Market Share by Country, 2020
Figure 65: Brazil Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 66: Brazil Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 68: Argentina Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 70: Colombia Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Country, 2020
Figure 73: Turkey Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 74: Turkey Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Age Related Macular Degeneration Drug Sales (K Units) Status 2016-2021
Figure 78: South Africa Age Related Macular Degeneration Drug Revenue (Million USD) Status 2016-2021
Figure 79: Roche Age Related Macular Degeneration Drug Revenue Market Share Globally (2019-2021)
Figure 80: Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Revenue Market Share Globally (2019-2021)
Figure 81: Novartis Age Related Macular Degeneration Drug Revenue Market Share Globally (2019-2021)
Figure 82: Kanghong Pharma Age Related Macular Degeneration Drug Revenue Market Share Globally (2019-2021)
Figure 83: Bayer HealthCare Age Related Macular Degeneration Drug Revenue Market Share Globally (2019-2021)
Figure 89: Global Age Related Macular Degeneration Drug Sales (K Units) Forecast (2022-2027)
Figure 90: Global Age Related Macular Degeneration Drug Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets